scispace - formally typeset
S

Stephen V. Faraone

Researcher at State University of New York Upstate Medical University

Publications -  1470
Citations -  155368

Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.

Papers
More filters
Journal ArticleDOI

Further evidence of association between behavioral inhibition and social anxiety in children.

TL;DR: This study adds to the growing literature suggesting an association between behavioral inhibition and social anxiety disorder and an inverse relationship between inhibition and disruptive behavior disorders.
Journal ArticleDOI

Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.

TL;DR: Though the level of risk is less than that with the APOE4 allele, the high prevalence of these disorders may result in substantial increases in future incidence of AD.
Journal ArticleDOI

Decreased volume of left and total anterior insular lobule in schizophrenia

TL;DR: The total insula volumes, and the left aINS(lbl) in particular, were significantly volumetrically smaller in schizophrenia compared to controls, and significantly correlated with bizarre behavior.
Journal ArticleDOI

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Vassily Trubetskoy, +432 more
- 08 Apr 2022 - 
TL;DR: In this article , a two-stage genome-wide association study of up to 76,755 individuals with schizophrenia and 243,649 control individuals was conducted, and the authors reported common variant associations at 287 distinct genomic loci.
Journal ArticleDOI

The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes.

TL;DR: In this article, the authors examined 1038 single-nucleotide polymorphisms (SNPs) spanning 51 candidate genes involved in the regulation of neurotransmitter pathways, particularly dopamine, norepinephrine and serotonin pathways, in addition to circadian rhythm genes.